SA
Sign upLog In
ARWR

ARWR Net Receivables

$8.56MQuarterly · USD

Period ending:

AnnualQuarterlyChart Studio →
ARWR FY Net ReceivablesUSD
ARWR FY Net Receivables1997-09-30: $10.42K1998-09-30: $3.18K1999-09-30: $11.30K2000-09-30: $1.28K2001-09-30: $640.002002-09-30: $0.002003-09-30: $0.002004-09-30: $51.84K2005-09-30: $33.45K2006-09-30: $74.21K2007-09-30: $276.06K2008-09-30: $86.60K2009-09-30: $147.26K2010-09-30: $930.68K2011-09-30: $1.61M2012-09-30: $2.47M2013-09-30: $83.66K2014-09-30: $0.002015-09-30: $0.002016-09-30: $75.00K2017-09-30: $67.80K2018-09-30: $327.38K2019-09-30: $661.36K2020-09-30: $845.67K2021-09-30: $10.26M2022-09-30: $1.41M2023-09-30: $0.002024-09-30: $0.002025-09-30: $6.82M$10.26M$0.00
1997-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ARWR net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 29 observations from Sep 30, 1997 to Sep 30, 2025.

Arrowhead Pharmaceuticals Inc Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
6,824,000
0
0
1,410,000
10,255,000
845,673
661,361
327,375
67,797
75,000
0
0
83,663
2,465,418
1,608,382
930,683
147,257
86,599
276,064
74,214
33,448
51,835
0
0
640
1,280
11,300
3,175
10,418

Compare net receivables

All ARWR financial metrics · ARWR stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.